General Information of the Compound
| Compound ID |
CP0429636
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-[6-(4-naphthalen-1-ylpiperazin-1-yl)hexyl]-1,1-dioxo-1,2-benzothiazol-3-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H31N3O3S
|
||||||||||||||||||
| Molecular Weight |
477.63
|
||||||||||||||||||
| Canonical SMILES |
O=C1N(CCCCCCN2CCN(CC2)c2cccc3ccccc23)S(=O)(=O)c2ccccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H31N3O3S/c31-27-24-13-5-6-15-26(24)34(32,33)30(27)17-8-2-1-7-16-28-18-20-29(21-19-28)25-14-9-11-22-10-3-4-12-23(22)25/h3-6,9-15H,1-2,7-8,16-21H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
CPJKSKGAJPQEPQ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Protein ID: PT00941, 5-hydroxytryptamine receptor 7
Protein ID: PT01005, D(2) dopamine receptor